| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |